All tags Cancer Genome rearrangements and mutation signatures in development and cancer

Genome rearrangements and mutation signatures in development and cancer

This conference will welcome over 18 speakers to Boston for three days of lectures, networking opportunities, and poster sessions. 

Merck Boston Auditorium, Boston, US
18-20 April, 2017

Program summary


This meeting will bring together leading researchers in genomics and classical mechanistic biology, in an effort to decode the information contained in mutation signatures, genome rearrangements, and alterations of karyotype in human disease. The program will highlight the latest developments in this exciting field. This meeting is co-sponsored by the Department of Cell Biology at Harvard Medical School, and we hope that it will also foster new collaborations between groups working in this research area. This meeting will select short talks from submitted abstracts.

Download the conference program

See who is presenting a poster

Meeting attendance is now approaching capacity. Online registration is currently unavailable. To secure a seat at the conference you must email Please note without an email confirmation from the team, attendance is not guaranteed. 

before April 17

"Local Student"**

Registration includes:

  • Attendance to scientific sessions and conference materials
  • Refreshments and lunches during the conference
  • Drinks and networking reception April 18th

**"Local Student" At this time, the limited number of “Local Student” discounts available for qualifying institutions have been claimed. Qualifying Institutions include: Harvard University, Harvard Medical School, Harvard School of Dental Medicine, Harvard T. H. Chan School of Public Health, Harvard-affiliated hospitals and institutions, and MIT. New registrants from these institutions who register using a work email address will be placed on a waitlist and contacted if a "Local Student” discount becomes available. Students and postdocs from qualifying institutions should register as “LOCAL STUDENT ($245)”, and faculty and other researchers from qualifying institutions should register as “LOCAL STUDENT ($245)”. 

Confirmation note: All registered attendees will receive an email confirmation from within 48 hours of registering. If you do not receive this confirmation email, please contact to secure your seat.

Keynote speakers

  • Titia de Lange, The Rockefeller Institute, US
    “Telomere crisis as a source of genome rearrangements”
  • Professor Sir Mike Stratton, Wellcome Trust Sanger Institute, UK
    (Keynote sponsored by Harvard Medical School, Department of Cell Biology)
    "Signatures of mutational processes in cancer"

Confirmed speakers


  • ​​​​​​Fred Alt, Boston Children's Hospital 
    “Recurrently breaking genes in brain precursor cells: are there any functional or disease-relevant overlaps with those of B cells?”
  • Angelika Amon, MIT, US
    “How aneuploidy affects tumorigenesis”
  • Rameen Beroukhim, Dana-Farber Cancer Institute , US
    “Mechanistic and selective forces shaping rearrangement profiles in cancer”
  • Peter Campbell, Wellcome Trust Sanger Institute, UK
    “Patterns of structural variation in 2,600 cancer genomes”
  • Don Cleveland, University of California- San Diego, US
    “Genome rearrangements and mutation signatures in development and cancer”
  • Luca Comai, University of California - Davis, US
    “Plant genome instability mediated by centromere failure”
  • Steve Elledge, Harvard Medical School , US
    “How aneuploidy drives cancer”
  • Gad Getz, Broad Institute, US
  • Dmitry Gordenin, NIEHS, US
    “Knowledge-based analyses of mutation signatures reveal sources and mechanistic details of mutagenesis in humans”
  • James Haber, Brandeis University, US
    “Mutations and chromosomal alterations arising from repair of double-strand breaks in budding yeast”
  • Emily Hatch, Fred Hutchinson Cancer Research Center, US
    “Causes/consequences of nuclear envelope rupture in micronuclei”
  • Maria Jasin, Memorial Sloan Kettering Cancer Center, US
    “Protecting the genome by homologous recombination”
  • Jim Lupski, Baylor College of Medicine, US
    “Complex genomic rearrangements (CGR) and multiple de novo CNV (MdnCNV) — what can they teach us about mutational mechanisms?”
  • Anna Malkova, University of Iowa Carver College of Medicine, US
    “Genetic instability resulting from DNA synthesis associated with double-strand break repair”
  • Serena Nik-Zainal, Wellcome Trust Sanger Institute, UK
    “Advances in the understanding of mutational signatures in human cells”
  • David Pellman, Dana-Farber Cancer Institute, US
    “Complex chromosomal rearrangements from nuclear envelope disruption”
  • Ralph Scully, Harvard Medical School, US
    “Mechanisms of genomic instability at stalled replication forks”

Selected Short Talks

  • Harveer Dev (University of Cambridge, UK)
    "Ectopic recruitment of 53BP1 to chromatin impairs mitotic DNA synthesis and promotes genome instability"
  • Catherine Freudenreich (Tufts University, US)​
    "Cytosine deamination mediates R-loop dependent CAG repeat frafility and instability"
  • Marcin Imielinski (Weill Cornell Medicine, UK)
    "Noncoding indel hotspots target lineage-defining genes in human cancer"
  • Benoit Laurent (Boston Children's Hospital, US)
    "m6A RNA methylation regulates the UV-induced DNA damage response"
  • Michael Lodato (Boston Children's Hospital, US)
    "Somatic mutations in human neurons reflect developmental and transcriptional histories"
  • Peter Park (Harvard Medical School, US)
    "A molecular portrait of microsatellite instability across 8000 cancers"
  • Mia Petljak (Wellcome Trust Sanger Institute, UK)
    "Investigation of activites of mutational processes over time reveals episodic nature of APOBEC mutagenesis in human cancer cells"
  • Jeff Sekelsky (University of North Carolina, US)
    "Synthesis-dependent strang annealing"
  • Jason Sheltzer (Cold Spring Harbor Laboratory, US)
    "Single-chromosome aneuploidy commonly functions as a tumor suppressor but can drive genome evolution"
  • Kyle Vrtis (Harvard Medical School, US)
    "Microhomology-mediated repair of collapsed replication forks in Xenopus egg extracts" 
  • ​Donate Weghorn (Harvard Medical School, US)
    "Bayesian inference of negative and positive selection in human cancers"


Meeting organizers

Topic overview:

  • Genome evolution in tumorigenesis
  • Mutational signatures in development and cancer
  • Analysis of structural variations in the cancer genome: detection, classification and underlying mechanisms
  • Basic mechanisms underlying genomic instability
  • Evolution of karyotype and mitotic control


Start TimeEnd Time
April 18, 2017 15:00April 20, 2017 17:00

Call for abstracts

Poster abstracts will be accepted through to April 1, 2017. After the deadline, please email for consideration.

Download our abstract guidelines 

Venue directions

Merck Boston Auditorium,
33 Avenue Louis Pasteur,
Boston, MA 02115
Map of Merck Boston Location

Terms and conditions

Delegates are advised to ensure they have adequate travel insurance to cover their attendance at the conference in case of incident, or cancellation due to circumstances beyond Abcam's control.

  • All fees paid to Abcam, including registration fees are non-refundable
  • Substitute delegates can be made at any time by contacting Abcam Events.


Important note regarding Hotel Accommodations:

Abcam does not have an affiliated hotel agency for this event.

Please be careful of direct approaches from companies offering hotel reservations for this event. Reservations made by unaffiliated organizations may appear to be for lower rates, however they may be illegitimate, have unreasonable cancellation or change penalties, or be completely non-refundable. Please be aware of, and report any unauthorized solicitation to Abcam.

​Interested in additional events? Find more with our full calendar now.